1. Home
  2. VIR vs IDT Comparison

VIR vs IDT Comparison

Compare VIR & IDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vir Biotechnology Inc.

VIR

Vir Biotechnology Inc.

HOLD

Current Price

$6.78

Market Cap

773.5M

Sector

Health Care

ML Signal

HOLD

Logo IDT Corporation Class B

IDT

IDT Corporation Class B

HOLD

Current Price

$52.19

Market Cap

1.2B

ML Signal

HOLD

Company Overview

Basic Information
Metric
VIR
IDT
Founded
2016
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Telecommunications Equipment
Sector
Health Care
Telecommunications
Exchange
Nasdaq
Nasdaq
Market Cap
773.5M
1.2B
IPO Year
2019
1996

Fundamental Metrics

Financial Performance
Metric
VIR
IDT
Price
$6.78
$52.19
Analyst Decision
Strong Buy
Analyst Count
11
0
Target Price
$25.73
N/A
AVG Volume (30 Days)
1.8M
158.8K
Earning Date
11-05-2025
12-04-2025
Dividend Yield
N/A
0.47%
EPS Growth
N/A
10.35
EPS
N/A
3.22
Revenue
$16,860,000.00
$1,244,681,000.00
Revenue This Year
N/A
$0.77
Revenue Next Year
$48.05
N/A
P/E Ratio
N/A
$16.19
Revenue Growth
N/A
2.52
52 Week Low
$4.16
$44.77
52 Week High
$14.45
$71.12

Technical Indicators

Market Signals
Indicator
VIR
IDT
Relative Strength Index (RSI) 61.51 58.08
Support Level $6.49 $47.30
Resistance Level $6.89 $53.99
Average True Range (ATR) 0.47 1.76
MACD 0.06 0.31
Stochastic Oscillator 83.17 70.40

Price Performance

Historical Comparison
VIR
IDT

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

About IDT IDT Corporation Class B

IDT Corp is a multinational holding company. It operates in the telecommunications and payment industries. It has four reportable business segments, Fintech, National Retail Solutions; net2phone and Traditional Communications, The Fintech segment is comprised of National Retail Solutions (NRS), an operator of a nationwide point of sale (POS) network providing payment processing, digital advertising, transaction data, and ancillary services, and BOSS Money, a provider of international money remittance and related value/payment transfer services. The net2phone segment provides unified cloud communications and telephony services to business customers.

Share on Social Networks: